怡合达(301029) - 2024 Q3 - 季度财报

Financial Performance - The company's revenue for Q3 2024 was ¥626,529,577.62, a decrease of 7.35% compared to the same period last year[2]. - Total operating revenue for Q3 2024 was ¥1,857,212,087.29, a decrease of 15.7% compared to ¥2,203,605,503.37 in Q3 2023[14]. - Net profit for Q3 2024 was ¥328,251,507.24, down 27.2% from ¥451,553,406.02 in the same period last year[15]. - The net profit attributable to shareholders for Q3 2024 was ¥105,560,565.60, an increase of 0.31% year-on-year[2]. - The total comprehensive income attributable to the parent company for Q3 2024 was CNY 328,251,507.24, a decrease from CNY 451,553,406.02 in Q3 2023, representing a decline of approximately 27.2%[18]. - Basic and diluted earnings per share for Q3 2024 were both CNY 0.57, down from CNY 0.78 in Q3 2023, indicating a decrease of 26.9%[18]. Cash Flow - The operating cash flow for the year-to-date period reached ¥609,822,214.00, reflecting a significant increase of 256.33%[6]. - Cash flow from operating activities for the period was CNY 609,822,214.00, significantly higher than CNY 171,140,056.65 in the same period last year, marking an increase of approximately 256.5%[18]. - Cash inflow from operating activities totaled CNY 1,737,122,615.50, slightly down from CNY 1,738,829,919.82 in the previous year[18]. - Cash outflow from operating activities decreased to CNY 1,127,300,401.50 from CNY 1,567,689,863.17, reflecting a reduction of about 28.0%[18]. - The net cash flow from investing activities was negative CNY 215,894,161.95, compared to negative CNY 150,482,650.05 in the previous year[18]. - The net cash flow from financing activities was negative CNY 266,388,982.64, worsening from negative CNY 153,943,935.24 in the same period last year[18]. - The ending balance of cash and cash equivalents was CNY 1,228,372,594.97, an increase from CNY 982,578,081.43 at the end of Q3 2023[19]. - The company reported a cash balance of RMB 1,236,041,466.77 at the end of September 2024, an increase from RMB 1,112,415,977.53 at the beginning of the period[11]. Assets and Liabilities - Total assets as of September 30, 2024, were ¥3,711,249,512.19, representing a 1.71% increase from the end of the previous year[2]. - Total assets increased to ¥3,711,249,512.19 from ¥3,648,928,036.48, representing a growth of 1.7%[13]. - Total liabilities decreased to ¥540,347,464.24 from ¥575,969,547.77, a reduction of 6.2%[13]. - The company's equity attributable to shareholders increased to ¥3,170,902,047.95, up by 3.19% from the previous year[2]. - The company's equity attributable to shareholders rose to ¥3,170,902,047.95 from ¥3,072,958,488.71, an increase of 3.2%[13]. Shareholder Information - The total number of common shareholders at the end of the reporting period is 21,047[7]. - The largest shareholder, Jin Liguo, holds 21.63% of the shares, totaling 124,720,322 shares[7]. - The number of restricted shares held by Jin Liguo decreased from 124,377,665 to 93,540,241 due to the release of 31,180,081 shares[9]. - The company has a total of 107,866,471 restricted shares released during the period[10]. - The top ten shareholders collectively hold significant stakes, with the top three shareholders accounting for over 50% of the total shares[8]. - The company has engaged in strategic partnerships, as indicated by the involvement of multiple investment firms among the top shareholders[8]. - The company is actively managing its shareholder structure, with several shareholders being part of a concerted action agreement[8]. - The total number of shares held by the top ten unrestricted shareholders is significant, indicating a strong base of support[8]. - The company has not reported any changes in the status of its preferred shareholders[9]. Operating Costs and Expenses - Total operating costs decreased to ¥1,502,216,168.99 from ¥1,678,851,760.02, reflecting a reduction of 10.5%[14]. - Research and development expenses were ¥81,706,480.42, a decrease of 14.9% compared to ¥95,998,068.20 in Q3 2023[15]. - The company reported a significant increase in cash and cash equivalents, with a net increase of ¥127,507,977.02, a 195.95% rise compared to the previous year[6]. - The company experienced a 100.24% increase in notes receivable, attributed to an increase in commercial acceptance bills received during the period[5]. - The company’s financial expenses increased significantly, with a reported amount of -¥26,616,769.57, reflecting a 518.51% change due to interest income from bank deposits[5]. - The company’s other income surged by 892.91% to ¥17,396,523.14, influenced by tax policy benefits for advanced manufacturing enterprises[5]. - Accounts receivable decreased to ¥725,239,596.59 from ¥813,851,942.12, a decline of 10.9%[12]. - Inventory increased to ¥493,637,314.22 from ¥471,051,702.12, reflecting a rise of 4.8%[12]. - The company reported a financial income of ¥27,420,718.55, significantly up from ¥5,025,059.40 in the previous year[15].